Nifty
Sensex
:
:
18258.25
61164.45
-10.15 (-0.06%)
-185.81 (-0.30%)

Pharmaceuticals & Drugs - Global

Rating :
47/99

BSE: 524494 | NSE: IPCALAB

2189.50
26-Oct-2021
  • Open
  • High
  • Low
  • Previous Close
  •  2234.00
  •  2268.00
  •  2171.00
  •  2223.90
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  288779
  •  6352.95
  •  2766.20
  •  1785.40

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 27,755.88
  • 27.73
  • 2
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 27,643.15
  • 0.37%
  • 5.54

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 46.29%
  • 0.72%
  • 7.61%
  • FII
  • DII
  • Others
  • 18.46%
  • 25.22%
  • 1.70%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 8.64
  • 11.32
  • 12.93

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 13.23
  • 28.95
  • 16.91

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 15.31
  • 41.43
  • 36.89

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 32.40
  • 32.99
  • 29.39

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 4.31
  • 4.28
  • 5.05

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 18.29
  • 19.32
  • 19.34

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Jun 21
Jun 20
Var%
Mar 21
Mar 20
Var%
Dec 20
Dec 19
Var%
Sep 20
Sep 19
Var%
Net Sales
1,565.79
1,534.40
2.05%
1,114.66
1,073.76
3.81%
1,409.83
1,212.86
16.24%
1,361.10
1,283.90
6.01%
Expenses
1,149.25
946.08
21.47%
885.75
905.30
-2.16%
1,042.90
939.20
11.04%
1,000.91
1,018.04
-1.68%
EBITDA
416.54
588.32
-29.20%
228.91
168.46
35.88%
366.93
273.66
34.08%
360.19
265.86
35.48%
EBIDTM
26.60%
38.34%
20.54%
15.69%
26.03%
22.56%
26.46%
20.71%
Other Income
21.02
12.09
73.86%
19.92
13.73
45.08%
15.38
18.13
-15.17%
15.45
14.80
4.39%
Interest
1.82
2.74
-33.58%
1.70
3.67
-53.68%
2.29
4.01
-42.89%
2.31
4.23
-45.39%
Depreciation
55.87
51.03
9.48%
52.50
63.94
-17.89%
53.52
50.83
5.29%
52.12
49.63
5.02%
PBT
379.87
546.64
-30.51%
194.63
114.58
69.86%
326.50
236.95
37.79%
321.21
226.80
41.63%
Tax
70.77
99.89
-29.15%
30.93
29.20
5.92%
56.73
36.89
53.78%
52.59
31.89
64.91%
PAT
309.10
446.75
-30.81%
163.70
85.38
91.73%
269.77
200.06
34.84%
268.62
194.91
37.82%
PATM
19.74%
29.12%
14.69%
7.95%
19.13%
16.49%
19.74%
15.18%
EPS
24.18
35.31
-31.52%
12.72
6.81
86.78%
20.93
15.64
33.82%
21.05
15.28
37.76%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Net Sales
5,451.38
5,394.94
4,619.03
3,745.69
3,257.76
3,156.19
2,867.11
3,144.40
3,281.77
2,805.94
2,355.96
Net Sales Growth
6.79%
16.80%
23.32%
14.98%
3.22%
10.08%
-8.82%
-4.19%
16.96%
19.10%
 
Cost Of Goods Sold
1,842.36
1,547.98
1,455.41
1,090.34
978.34
939.40
903.04
968.00
963.06
955.10
800.91
Gross Profit
3,609.02
3,846.96
3,163.62
2,655.35
2,279.42
2,216.79
1,964.07
2,176.40
2,318.71
1,850.84
1,555.05
GP Margin
66.20%
71.31%
68.49%
70.89%
69.97%
70.24%
68.50%
69.22%
70.65%
65.96%
66.00%
Total Expenditure
4,078.81
3,913.71
3,728.56
3,067.42
2,815.78
2,740.77
2,593.42
2,630.33
2,569.79
2,268.34
1,928.47
Power & Fuel Cost
-
207.10
201.22
176.50
161.92
151.00
141.67
135.94
127.91
104.79
83.78
% Of Sales
-
3.84%
4.36%
4.71%
4.97%
4.78%
4.94%
4.32%
3.90%
3.73%
3.56%
Employee Cost
-
1,013.57
921.23
787.40
735.88
695.98
625.58
566.70
497.99
391.79
335.49
% Of Sales
-
18.79%
19.94%
21.02%
22.59%
22.05%
21.82%
18.02%
15.17%
13.96%
14.24%
Manufacturing Exp.
-
524.21
471.80
374.26
366.92
404.52
387.75
439.11
415.69
331.73
275.82
% Of Sales
-
9.72%
10.21%
9.99%
11.26%
12.82%
13.52%
13.96%
12.67%
11.82%
11.71%
General & Admin Exp.
-
242.22
249.90
271.85
268.52
246.68
245.42
246.73
255.40
205.02
178.12
% Of Sales
-
4.49%
5.41%
7.26%
8.24%
7.82%
8.56%
7.85%
7.78%
7.31%
7.56%
Selling & Distn. Exp.
-
324.86
359.15
317.84
277.62
280.74
223.67
245.00
231.18
212.94
196.09
% Of Sales
-
6.02%
7.78%
8.49%
8.52%
8.89%
7.80%
7.79%
7.04%
7.59%
8.32%
Miscellaneous Exp.
-
53.77
69.85
49.23
26.58
22.45
66.29
28.85
78.56
66.97
196.09
% Of Sales
-
1.00%
1.51%
1.31%
0.82%
0.71%
2.31%
0.92%
2.39%
2.39%
2.47%
EBITDA
1,372.57
1,481.23
890.47
678.27
441.98
415.42
273.69
514.07
711.98
537.60
427.49
EBITDA Margin
25.18%
27.46%
19.28%
18.11%
13.57%
13.16%
9.55%
16.35%
21.69%
19.16%
18.15%
Other Income
71.77
129.19
86.50
74.66
58.08
54.76
40.77
58.69
51.97
39.88
48.34
Interest
8.12
12.27
19.77
22.24
27.57
26.91
34.56
32.13
30.23
36.48
44.39
Depreciation
214.01
209.17
210.50
182.42
177.73
172.95
163.26
179.55
103.13
86.73
67.13
PBT
1,222.21
1,388.98
746.70
548.27
294.76
270.32
116.64
361.08
630.59
454.27
364.31
Tax
211.02
240.14
135.33
104.24
51.11
67.52
20.44
101.93
152.39
129.94
88.11
Tax Rate
17.27%
17.29%
18.12%
19.01%
17.34%
24.98%
17.52%
28.23%
24.17%
28.60%
24.19%
PAT
1,011.19
1,147.71
614.13
447.39
243.65
202.80
96.20
259.15
478.20
324.33
276.20
PAT before Minority Interest
1,009.60
1,148.84
611.37
444.03
243.65
202.80
96.20
259.15
478.20
324.33
276.20
Minority Interest
-1.59
-1.13
2.76
3.36
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PAT Margin
18.55%
21.27%
13.30%
11.94%
7.48%
6.43%
3.36%
8.24%
14.57%
11.56%
11.72%
PAT Growth
9.07%
86.88%
37.27%
83.62%
20.14%
110.81%
-62.88%
-45.81%
47.44%
17.43%
 
EPS
79.68
90.44
48.39
35.26
19.20
15.98
7.58
20.42
37.68
25.56
21.77

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Shareholder's Funds
4,701.65
3,627.48
3,122.39
2,688.57
2,455.26
2,259.19
2,208.43
1,959.66
1,553.78
1,254.01
Share Capital
25.37
25.27
25.27
25.24
25.24
25.24
25.24
25.24
25.24
25.17
Total Reserves
4,676.28
3,590.27
3,097.12
2,663.01
2,430.02
2,233.95
2,183.19
1,934.42
1,528.54
1,228.70
Non-Current Liabilities
217.10
290.29
313.40
419.42
548.32
662.57
699.57
459.45
509.52
433.15
Secured Loans
36.54
88.80
133.94
234.01
347.22
433.63
447.65
292.12
366.21
330.18
Unsecured Loans
0.00
14.17
6.91
0.00
4.52
50.64
55.56
1.88
0.00
0.00
Long Term Provisions
38.56
32.23
25.28
25.88
24.55
20.22
18.03
14.93
12.21
8.72
Current Liabilities
1,133.13
1,326.42
1,097.50
1,007.57
955.93
969.95
904.36
791.45
633.65
640.17
Trade Payables
666.17
609.85
524.32
423.47
396.54
421.11
306.59
340.99
268.37
234.52
Other Current Liabilities
203.12
304.57
274.74
266.75
316.41
297.50
236.44
250.88
166.00
175.33
Short Term Borrowings
149.20
310.95
209.69
239.04
177.30
184.85
325.35
143.94
157.14
201.36
Short Term Provisions
114.64
101.05
88.75
78.31
65.68
66.49
35.98
55.64
42.14
28.96
Total Liabilities
6,066.41
5,257.82
4,548.83
4,115.56
3,959.51
3,891.71
3,812.36
3,210.56
2,696.95
2,327.33
Net Block
2,072.43
2,058.73
1,940.38
1,952.96
1,983.27
2,014.18
1,800.43
1,353.59
1,104.23
944.08
Gross Block
3,185.55
2,985.73
2,632.86
2,464.33
2,318.22
2,176.95
2,546.33
1,932.05
1,579.07
1,338.55
Accumulated Depreciation
1,113.12
927.00
692.48
511.37
334.95
162.77
745.90
578.46
474.84
394.47
Non Current Assets
2,629.45
2,402.11
2,171.08
2,170.08
2,217.69
2,269.79
2,198.38
1,609.14
1,299.78
1,117.30
Capital Work in Progress
234.82
133.28
66.33
73.00
94.64
128.74
267.22
164.90
129.17
94.51
Non Current Investment
111.43
71.31
30.05
17.52
22.24
25.82
16.19
9.00
8.87
33.93
Long Term Loans & Adv.
184.42
124.68
128.36
115.83
103.58
78.44
103.47
71.26
47.49
37.12
Other Non Current Assets
26.35
14.11
5.96
10.77
13.96
22.61
11.07
10.39
10.02
7.66
Current Assets
3,436.96
2,855.71
2,377.75
1,945.48
1,741.82
1,621.92
1,613.98
1,601.42
1,397.17
1,210.03
Current Investments
393.83
238.25
90.38
69.35
113.57
0.00
0.00
0.15
0.15
0.15
Inventories
1,594.81
1,323.12
1,072.50
880.59
882.22
837.42
926.56
847.58
741.03
669.89
Sundry Debtors
811.75
895.20
681.51
602.27
500.16
445.87
353.00
449.79
417.81
344.88
Cash & Bank
365.07
180.92
282.30
150.57
35.85
175.54
124.79
76.01
58.24
12.16
Other Current Assets
271.50
195.92
221.21
228.26
210.02
163.09
209.63
227.89
179.94
182.95
Short Term Loans & Adv.
32.86
22.30
29.85
14.44
15.56
17.31
36.19
53.84
31.22
27.73
Net Current Assets
2,303.83
1,529.29
1,280.25
937.91
785.89
651.97
709.62
809.97
763.52
569.86
Total Assets
6,066.41
5,257.82
4,548.83
4,115.56
3,959.51
3,891.71
3,812.36
3,210.56
2,696.95
2,327.33

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Cash From Operating Activity
1,090.13
570.35
501.03
341.13
281.91
708.65
455.29
522.29
388.77
353.84
PBT
1,381.28
738.89
546.46
290.53
262.06
116.64
361.08
630.59
454.27
364.31
Adjustment
190.77
247.37
187.36
192.51
174.86
211.11
187.91
139.92
126.16
156.99
Changes in Working Capital
-236.33
-263.69
-121.97
-84.44
-103.73
410.30
-18.68
-117.72
-100.10
-87.39
Cash after chg. in Working capital
1,335.72
722.57
611.85
398.60
333.19
738.05
530.31
652.79
480.33
433.91
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-245.59
-152.22
-110.82
-57.47
-51.28
-29.40
-75.02
-130.50
-91.56
-80.07
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-520.69
-509.65
-165.06
-135.40
-148.82
-218.33
-676.40
-369.01
-259.87
-285.90
Net Fixed Assets
-302.10
-284.34
-46.98
-60.09
-105.61
466.60
-716.66
-362.17
-275.00
-298.69
Net Investments
-219.12
-326.48
-106.61
-4.05
-114.15
-15.57
-52.96
-6.96
20.86
6.14
Others
0.53
101.17
-11.47
-71.26
70.94
-669.36
93.22
0.12
-5.73
6.65
Cash from Financing Activity
-305.82
-136.54
-183.20
-130.41
-159.13
-461.51
250.54
-136.13
-82.93
-71.81
Net Cash Inflow / Outflow
263.62
-75.84
152.77
75.32
-26.04
28.81
29.43
17.15
45.97
-3.87
Opening Cash & Equivalents
295.39
370.92
218.15
142.83
168.87
140.06
74.25
56.69
10.72
9.14
Closing Cash & Equivalent
559.01
295.39
370.92
218.15
142.83
168.87
103.68
74.25
56.69
10.72

Financial Ratios

Consolidated /

Standalone
Description
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Book Value (Rs.)
370.65
286.15
247.12
213.02
194.55
179.02
174.99
155.28
123.12
99.63
ROA
20.29%
12.47%
10.25%
6.03%
5.17%
2.50%
7.38%
16.19%
12.91%
13.03%
ROE
27.63%
18.15%
15.28%
9.47%
8.60%
4.31%
12.43%
27.22%
23.10%
23.97%
ROCE
30.92%
19.92%
16.53%
9.94%
9.44%
4.82%
13.78%
27.92%
24.38%
23.78%
Fixed Asset Turnover
1.76
1.65
1.48
1.37
1.43
1.23
1.42
1.89
1.95
2.04
Receivable days
57.48
61.90
62.09
61.27
53.75
50.16
46.12
47.78
49.05
54.65
Inventory Days
98.25
94.05
94.47
97.98
97.70
110.76
101.93
87.49
90.74
87.21
Payable days
52.96
49.85
51.13
50.35
52.23
52.92
39.11
36.45
31.30
30.47
Cash Conversion Cycle
102.77
106.10
105.43
108.90
99.22
108.00
108.95
98.82
108.49
111.38
Total Debt/Equity
0.05
0.13
0.15
0.23
0.29
0.38
0.42
0.31
0.40
0.48
Interest Cover
114.20
38.77
25.65
11.69
11.05
4.38
12.24
21.86
13.45
9.21

News Update:


  • Ipca Laboratories’ arm picks up additional 20% share capital of Bayshore
    1st Oct 2021, 12:26 PM

    With this acquisition, Bayshore is now wholly owned by Ipca Pharmaceuitcals, Inc

    Read More
  • Ipca Laboratories reports 31% fall in Q1 consolidated net profit
    5th Aug 2021, 15:24 PM

    Total consolidated income of the company increased by 2.61% at Rs 1,586.81 crore for Q1FY22

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.